Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Encapsulated model

Fig. 12.1 Main structural models of graphene-metal oxide hybrids, (a) Anchored model oxide particles are anchored to the graphene surface, (b) Encapsulated model oxide particles are encapsulated by graphene, (c) Sandwich-like model graphene is sandwiched between the metal oxide layers, (d) Layered model a structure composed of alternating layers of oxide nanoparticles and graphene, (e) Mixed model graphene and oxide particles are mechanically mixed and graphene sheets form a conductive network among the oxide particles. Red metal oxide Blue graphene. Reprinted with permission from [41]. Copyright 2012, Elsevier B.V. Fig. 12.1 Main structural models of graphene-metal oxide hybrids, (a) Anchored model oxide particles are anchored to the graphene surface, (b) Encapsulated model oxide particles are encapsulated by graphene, (c) Sandwich-like model graphene is sandwiched between the metal oxide layers, (d) Layered model a structure composed of alternating layers of oxide nanoparticles and graphene, (e) Mixed model graphene and oxide particles are mechanically mixed and graphene sheets form a conductive network among the oxide particles. Red metal oxide Blue graphene. Reprinted with permission from [41]. Copyright 2012, Elsevier B.V.
Debenedetti and coworkers (88,89) provided one of the first examples of microencapsulation of a drug in the polymeric matrix. Richard and coworkers (90) provided a recent example of the microencapsulation process when they produced microparticles with the encapsulated model protein that showed sustained release. Foster and coworkers (87) also reported precipitation of copper-indomethacin by PVP with a 96-fold enhancement in the dissolution rate of indomethacin. These examples clearly demonstrated the advantages of using supercritical fluid processing for the preparation of polymer-drug formulations with potentially improved therapeutic properties. [Pg.358]

The amount of encapsulated model drug (retinyl acetate or progesterone) per mg of dried LS was determined through solubilization of LS in ethyl acetate at 60°C. Following filtration, the solution was analyzed by reverse-phase high-performance liquid chromatography (HPLC) to find the drug content. [Pg.13]

Fig. 7.11 Typical drug release profile of gas- and drug-filled microcapsule formulations. Percent release of an encapsulated model drug in physiological buffer media as a function of time. Storage under stirring for about 100 min at 37°C shows that just a baseline concentration of free drug is... Fig. 7.11 Typical drug release profile of gas- and drug-filled microcapsule formulations. Percent release of an encapsulated model drug in physiological buffer media as a function of time. Storage under stirring for about 100 min at 37°C shows that just a baseline concentration of free drug is...
PHB microcapsules with encapsulated model drug - methylene green have already been reported. The prospects for development and investigation of systems with biological activity based on microcapsules from polyhydroxyal-kanoates look bright. [Pg.310]


See other pages where Encapsulated model is mentioned: [Pg.178]    [Pg.327]    [Pg.327]    [Pg.548]    [Pg.187]    [Pg.156]    [Pg.30]    [Pg.29]    [Pg.15]    [Pg.906]    [Pg.402]    [Pg.415]    [Pg.178]    [Pg.36]    [Pg.350]    [Pg.217]    [Pg.85]   
See also in sourсe #XX -- [ Pg.327 ]




SEARCH



Encapsulation process structural model

© 2024 chempedia.info